Leakage of highly active drugs will seriously endanger the safety of operators – therefore, as more and more highly active compounds are approved as new drugs, pharmaceutical companies have more and more requirements for the closed production of tablet drugs . Drugs of OEB 3 level (OEL<100 µg/m3) need to be evaluated during the production process […]

Enterprises should take effective quality control measures in drug storage and other links to ensure drug quality. Enterprises should adopt a forward-looking or retrospective approach to assess, control, communicate and review the quality risks in the drug circulation process [1]. The management of drug storage conditions is an important guarantee to ensure the quality, safety

The high cost of medicines has repeatedly become a major bottleneck in the healthcare industry as large populations cannot afford prescription treatments. At the molecular level, many innovations are underway, including various recombinant monoclonal antibodies (mABs), antibody drug conjugates (ADCs), and gene therapies. In the case of targeted gene therapy, it is crucial and challenging